James O. Palmer
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James O. Palmer.
Cancer | 1986
Robert W. McDivitt; Kenneth R. Stone; R. Bruce Craig; James O. Palmer; John S. Meyer; Walter C. Bauer
Flow cytometric DNA analysis was performed on 168 consecutive primary operable breast cancers and the results correlated with thymidine labeling, estrogen receptor (ER) and progesterone receptor values, and various histologic parameters. Seventy‐five cancers (45.0%) were diploid and 93 (55.0%) aneuploid. In 83.9% of aneuploid cancers, the DNA index fell between 1.1 and 2.0. Thirteen cancers were hypertetraploid and three hypodiploid. The percent of S‐phase cancers (SpF) varied from 1.1% to 24.4%, with a mean of 8.0% and a median of 7.1%. The mean SpF of diploid cancers was 5.2%; of aneuploid cancers, 10.3%. There was no significant correlation between SpF or ploidy and tumor size or axillary lymph node status. The thymidine labeling index (TLI) varied from 0.2 to 23.1, with a mean of 7.5 and a median of 6.1. There was good correlation between TLI and SpF (r = 0.892, P = 0.0001). ER‐negative tumors had a significantly higher mean SpF (10.3%) than did ER‐positive tumors (6.7%), but there was no significant correlation between ploidy and receptor positivity or negativity. There was a good correlation between invasive tumor necrosis, poor cytologic differentiation, aneuploidy, and above‐median SpF. Only a fair correlation was observed between mitotic rate and SpF. A classification of invasive breast cancers based on ploidy and SpF is proposed.
Steroids | 1989
Richard J. Auchus; James O. Palmer; H.L. Carrell; Douglas F. Covey
The conversion of estrone to 14,15-secoestratrien-15-ynes, inactivators of estradiol dehydrogenase from human term placenta, is described. The optically pure precursor 7-acetoxy-octahydro-2-phenanthrenecarboxylic acid methyl ester is prepared from estrone in five steps and 40% yield. The unsubstituted propargylic secoestratriene diol, a mechanism-based inactivator of estradiol dehydrogenase, and the corresponding acetylenic ketone, an affinity label inactivator of the same enzyme, arise from the phenanthrene ester in three and four steps. The propargylic secoestratriene diol also competes with [3H]estradiol for binding to calf uterus estrogen receptor and possesses weak uterotrophic activity.
Cancer | 1988
James O. Palmer; Robert W. McDivitt; Kenneth R. Stone; Mary Anne Rudloff; Juan G. Gonzalez
This study investigated two hypotheses: (1) sufficient cells may be obtained by needle aspiration of breast nodules to produce good flow cytometric DNA profiles; and (2) benign breast lesions do not produce aneuploid GOG1 peaks, and therefore a distinct aneuploid peak is sufficient for a diagnosis of malignancy. Breast specimens received in Surgical Pathology between December 1985 and February 1987 were aspirated, and the cells stained with propidium iodide for flow cytometric DNA analysis. A total of 344 specimens were aspirated, of which 204 (59%) were malignant and 140 (41%) benign. One hundred fifty‐three malignant and 111 benign specimens contained sufficient cells for analysis. Cytologic smears were available for 177 malignant and 123 benign specimens. DNA histograms were considered diagnostic of malignancy if an aneuploid peak was present which contained at least 20% of the cells in the distribution, and had a DNA index ≥1.2. Using these criteria, 73 of 153 (48%) carcinomas could be identified. None of the benign lesions satisfied these criteria. One fibroadenoma with atypical hyperplasia produced a distinct peak which contained < 5% of the cells in the histogram, and had a DNA index of 1.25. Flow cytometric analysis provides objective data that complement the subjective cytologic interpretation of fine needle aspirates.
Cancer Research | 1987
Timothy L. Ratliff; James O. Palmer; Janet Mcgarr; Eric J. Brown
American Journal of Clinical Pathology | 1991
Nils M. Diaz; James O. Palmer; Robert W. McDivitt
Journal of Endourology | 1987
Ralph V. Clayman; Jeff Elbers; James O. Palmer; William Wassynger
Cancer Research | 1987
Amy Bear; Ralph V. Clayman; Jeffrey Elbers; Catherine Limas; Nancy Wang; Ken Stone; Roger L. Gebhard; William F. Prigge; James O. Palmer
Cytometry | 1985
Kenneth R. Stone; R. Bruce Craig; James O. Palmer; S E Rivkin; Robert W. McDivitt
Journal of Clinical Psychology | 1953
Frank M. Strange; James O. Palmer
Journal of Clinical Psychology | 1952
James O. Palmer; Ivan N. Mensh; Joseph D. Matarazzo